Brief: Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement With Innoviva
04/03/2024 21:04
March 4 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES $35 MILLION SECURED
CREDIT
AGREEMENT WITH INNOVIVA
* ARMATA PHARMACEUTICALS- PROCEEDS FROM NEW FINANCING TO BE
USED
TO ADVANCE CO'S LEAD THERAPEUTIC PHAGE CANDIDATES, INCLUDING
AP‐PA02 AND AP‐SA02
Source text for Eikon: ID:nPnsdsTya
Further company coverage: ARMP.A
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles